References of "CAVALIER, Etienne"
     in
Bookmark and Share    
See detailVitamin D, 1-84 PTH and KDIGO Guidelines
CAVALIER, Etienne ULg

Conference (2011, November 16)

Detailed reference viewed: 27 (0 ULg)
Full Text
Peer Reviewed
See detailVitamin D, cardiovascular disease and mortality
Pilz, Stefan; Tomaschitz, Andreas; März, Winfried et al

in Clinical Endocrinology (2011), 75(5), 575-84

A poor vitamin D status, i.e. low serum levels of 25-hydroxyvitamin D (25[OH]D), is common in the general population. This finding is of concern not only because of the classic vitamin D effects on ... [more ▼]

A poor vitamin D status, i.e. low serum levels of 25-hydroxyvitamin D (25[OH]D), is common in the general population. This finding is of concern not only because of the classic vitamin D effects on musculoskeletal outcomes, but also because expression of the vitamin D receptor (VDR) and vitamin D metabolizing enzymes in the heart and blood vessels suggests a role of vitamin D in the cardiovascular system. VDR-knockout mice suffer from cardiovascular disease (CVD) and various experimental studies suggest cardiovascular-protection by vitamin D, including anti-atherosclerotic, anti-inflammatory and direct cardio-protective actions, beneficial effects on classic cardiovascular risk factors as well as suppression of parathyroid hormone (PTH) levels. In epidemiological studies, low levels of 25(OH)D are associated with increased risk of CVD and mortality. Data from randomized controlled trials (RCTs) are sparse and have partially, but not consistently, shown some beneficial effects of vitamin D supplementation on cardiovascular risk factors (e.g. arterial hypertension). We have insufficient data on vitamin D effects on cardiovascular events, but meta-analyses of RCTs indicate that vitamin D may modestly reduce all-cause mortality. Despite accumulating data suggesting that a sufficient vitamin D status may protect against CVD, we still must wait for results of large-scale RCTs before raising general recommendations for vitamin D in the prevention and treatment of CVD. In current clinical practice the overall risks and costs of vitamin D supplementation should be weighed against the potential adverse consequences of untreated vitamin D deficiency [less ▲]

Detailed reference viewed: 33 (1 ULg)
Full Text
See detailLes biomarqueurs de la lésion rénale: limites actuelles et perspectives
CAVALIER, Etienne ULg

Conference (2011, October 03)

Detailed reference viewed: 6 (2 ULg)
Full Text
Peer Reviewed
See detailMaintenir la PTH entre 2 et 9 fois la valeur de référence supérieure du Laboratoire: d'accord, mais quelle valeur???
CAVALIER, Etienne ULg; DELANAYE, Pierre ULg; Souberbielle, Jean-Claude

in Néphrologie & Thérapeutique (2011, October), 7(5), 411-44727

Detailed reference viewed: 25 (0 ULg)
Full Text
Peer Reviewed
See detailTumor-induced osteomalacia: The tumor may stay hidden!
van der Rest, Catherine; CAVALIER, Etienne ULg; KAUX, Jean-François ULg et al

in Clinical Biochemistry (2011), 44(14-15), 1264-6

We report the case of a patient with severe muscular and articular tenderness that caused almost complete immobility. This subject had severe hypophosphatemia due to hyperphosphaturia. Fibroblast growth ... [more ▼]

We report the case of a patient with severe muscular and articular tenderness that caused almost complete immobility. This subject had severe hypophosphatemia due to hyperphosphaturia. Fibroblast growth factor 23 (FGF-23) was abnormally high and the diagnostic of tumor-induced osteomalacia was made. Despite multiple tests, the tumor was not localized. In this report, we discuss different possible investigations to localize the tumor. Lastly, we review the potential therapy available when tumor is not found and can thus not be excised. [less ▲]

Detailed reference viewed: 48 (17 ULg)
Full Text
See detailDosages de la PTH et de la vitamine D: en est-on enfin au bout du tunnel?
CAVALIER, Etienne ULg

Conference (2011, September 30)

Detailed reference viewed: 13 (5 ULg)
Full Text
Peer Reviewed
See detailEstimating glomerular filtration rate in Asian subjects: where do we stand?
DELANAYE, Pierre ULg; CAVALIER, Etienne ULg; Mariat, Christophe et al

in Kidney International (2011), 80(5), 439-440

Detailed reference viewed: 15 (2 ULg)
Full Text
Peer Reviewed
See detailEstimation du débit de filtration glomérulaire en transplantation rénale: étude multicentrique d'évaluation de la performance de la cystatine C
Masson, I.; Maillard, N.; Jaafar, A. et al

in Néphrologie & Thérapeutique (2011, September), 7(5), 290-91

Detailed reference viewed: 16 (0 ULg)
Full Text
Peer Reviewed
See detailDétection de la maladie rénale chronique dans la population générale: créatinine ou cystatine C?
DELANAYE, Pierre ULg; CAVALIER, Etienne ULg; KRZESINSKI, Jean-Marie ULg

in Néphrologie & Thérapeutique (2011, September), 7(5), 298

Detailed reference viewed: 19 (3 ULg)